| http://www.w3.org/ns/prov#value | - Apotherapy will develop state-of-the-art vehicles for the efficient and targeted delivery of the CD40 ligand to cancer cells and assess their therapeutic impact either alone or in combination with other agents, including novel antagonists of the anti-apoptotic PI3 kinase/Akt pathway which is frequently activated in human tumors.
|
